NASDAQ:MEDS Wellgistics Health (MEDS) Stock Price, News & Analysis $4.64 -1.43 (-23.56%) As of 09/17/2026 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsNews and TrendsOwnershipSEC Filings About Wellgistics Health Stock (NASDAQ:MEDS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Wellgistics Health alerts:Sign Up Key Stats Today's Range$4.03▼$6.7550-Day Range$0.85▼$6.0752-Week Range$0.82▼$75.00Volume7.07 million shsAverage Volume13.32 million shsMarket Capitalization$14.85 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Wellgistics Health, Inc. (NASDAQ:MEDS) is a healthcare technology and pharmaceutical distribution company focused on improving access to prescription medicines. The company provides infrastructure designed to connect healthcare providers, pharmacies, pharmaceutical manufacturers and patients within the prescription-drug supply chain. Its business activities include pharmaceutical distribution and technology-enabled services intended to support medication ordering, fulfillment and delivery. Wellgistics Health has also focused on solutions for digital health and specialty-care providers, including platforms that can help coordinate prescriptions and pharmacy services. The company primarily serves the U.S. healthcare market. Publicly available information about its historical development and executive leadership is limited, and its product offerings and strategic priorities may evolve as the business expands.AI Generated. May Contain Errors. Read More Wellgistics Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks6th Percentile Overall ScoreMEDS MarketRank™: Wellgistics Health scored higher than 6% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingWellgistics Health has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageWellgistics Health has only been the subject of 1 research reports in the past 90 days.Read more about Wellgistics Health's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Wellgistics Health is -0.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Wellgistics Health is -0.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted7.67% of the float of Wellgistics Health has been sold short.Short Interest Ratio / Days to CoverWellgistics Health has a short interest ratio ("days to cover") of 0.16, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Wellgistics Health has recently increased by 5.54%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldWellgistics Health does not currently pay a dividend.Dividend GrowthWellgistics Health does not have a long track record of dividend growth. News and Social Media2.7 / 5News Sentiment0.26 News SentimentWellgistics Health has a news sentiment score of 0.26. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.79 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 11 news articles for Wellgistics Health this week, compared to 2 articles on an average week.Search Interest6 people have searched for MEDS on MarketBeat in the last 30 days. This is an increase of 500% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Wellgistics Health insiders have not sold or bought any company stock.Percentage Held by Insiders29.10% of the stock of Wellgistics Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions5.68% of the stock of Wellgistics Health is held by institutions.Read more about Wellgistics Health's insider trading history. Receive MEDS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Wellgistics Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MEDS Stock News HeadlinesContrasting LifeStance Health Group (NASDAQ:LFST) and Wellgistics Health (NASDAQ:MEDS)September 11, 2026 | americanbankingnews.comDataMeds AI and Tollo Health Partner with the NFL Alumni Association for Health Lives Here National CampaignSeptember 8, 2026 | markets.businessinsider.com$20,000 gold before year end?President Trump reposted a warning from precious metals expert Jim Rickards, tying the November midterms and America's $40 trillion national debt to a potential surge in gold prices, with some forecasts pointing to $10,000 or even $20,000 gold. Dr. David Eifrig, a 40-year market veteran and former Goldman Sachs Vice President, says an unusual plan involving Trump and two other top officials could fuel the biggest gold bull run in decades. Eifrig has shared his top gold pick tied to this developing story. | Stansberry Research (Ad)DataMeds, Tollo Health Partner NFL Alumni for Rural Health AccessSeptember 8, 2026 | usatoday.comDataMEDS AI Officially Begins Trading Under Stock Symbol ‘MEDS’ on the NASDAQ Capital MarketsJuly 22, 2026 | usatoday.comWELLGISTICS HEALTH, INC. OFFICIALLY CHANGES CORPORATE NAME TO DATAMEDS AI, INC.July 21, 2026 | prnewswire.comWellgistics Health, Inc.: Wellgistics Health Announces Updated Record Date for Distribution of Dream Bowl 2026 Meme Coin to StockholdersJuly 20, 2026 | finanznachrichten.deRubenstein Public Relations Named Agency of Record for Wellgistics Health, Inc.July 16, 2026 | globenewswire.comSee More Headlines MEDS Stock Analysis - Frequently Asked Questions How have MEDS shares performed this year? Wellgistics Health's stock was trading at $20.00 on January 1st, 2026. Since then, MEDS shares have decreased by 76.8% and is now trading at $4.64. How were Wellgistics Health's earnings last quarter? Wellgistics Health, Inc. (NASDAQ:MEDS) announced its earnings results on Monday, August, 17th. The company reported ($7.13) EPS for the quarter. The company had revenue of $1.78 million for the quarter. When did Wellgistics Health's stock split? Wellgistics Health's stock reverse split on Tuesday, May 26th 2026.The 1-50 reverse split was announced on Wednesday, May 20th 2026. The number of shares owned by shareholders was adjusted after the closing bell on Monday, May 25th 2026. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. How do I buy shares of Wellgistics Health? Shares of MEDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Wellgistics Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Wellgistics Health investors own include NVIDIA (NVDA), Biora Therapeutics (BIOR), Citius Pharmaceuticals (CTXR), Meta Platforms (META) and Advanced Micro Devices (AMD). Company Calendar Last Earnings8/17/2026Today9/17/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2d) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 As of 2 days ago, MEDS's financial health entered the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Distributors Current SymbolNASDAQ:MEDS Previous SymbolNASDAQ:WGRX CIK2030763 Webwww.wellgisticshealth.com Phone1-843-302-1785FaxN/AEmployees31Year FoundedN/AProfitability EPS (Trailing Twelve Months)($46.13) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$101.28 million Net Margins-1,100.16% Pretax Margin-1,100.17% Return on EquityN/A Return on Assets-171.81% Debt Debt-to-Equity RatioN/A Current Ratio0.14 Quick Ratio0.10 Sales & Book Value Annual Sales$23.34 million Price / Sales0.64 Cash FlowN/A Price / Cash FlowN/A Book Value($6.94) per share Price / Book-0.67Miscellaneous Outstanding Shares3,200,000Free Float2,267,000Market Cap$14.85 million OptionableN/A Beta-1.77 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report This page (NASDAQ:MEDS) was last updated on 9/18/2026 by MarketBeat.com Staff. From Our PartnersIran War: Why Is Trump Protecting THEM?A powerful Middle Eastern government is reportedly seeking US intelligence, targeting help, and military prote...Banyan Hill Publishing | SponsoredGold Miners Post Record Cash Flow Even as Prices Pull BackThe four largest gold miners are generating record free cash flow, even with gold pulling back from recent hig...Golden Portfolio | SponsoredMusk says UBI is coming. I say it's already here.Elon Musk says AI could make money irrelevant by 2036. One income program already exists today, funded not by ...Freedom Financial | SponsoredMILLIONAIRE MASTERCLASS INVITE: AltucherJames Altucher says Elon Musk is preparing an unprecedented project set to surface on September 25. Altuche...Paradigm Press | SponsoredA “bloodbath” Is ComingReports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...TradeSmith | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredThe dollar reset no one told you aboutPorter Stansberry says a dollar reset is underway - one that has happened only once before in America's 250-ye...Porter & Company | Sponsored“This is the Perfect Tech Stock”Jeff Brown, the tech investor who identified Nvidia in 2016 before its 37,000% run, has flagged a new AI compa...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Wellgistics Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Wellgistics Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MEDS Stock Alerts